Check out Jim Cramer's latest trading recommendations on "Action Alerts Plus". (Updates from 10:36 a.m. ET with closing information.)
NEW YORK (TheStreet) -- Here's what Jim Cramer had to say on CNBC's "Squawk on the Street" Monday.
Although Deutsche Bank downgraded Goodyear Tire & Rubber (GT) to hold from buy, Cramer wasn't so sure about it. He said the stock has been red-hot this year. GT plummeted 6.7% to $21.12.
First Horizon National (FHN) missed on earnings estimates. Cramer said he can't figure out what's wrong with the company but he does like the stock. FHN fell 1.2% to $10.88. Cramer said he's surprised by Cimarex Energy's (XEC) current stock price, saying the company is "worth a lot more than it's selling for." XEC dropped 1.3% to $108.99. Cramer suggested commodity food companies are doing better now in the market, and reminded investors Dean Foods (DF) is big in milk. DF rose 1% to $18.42. Schlumberger's (SLB) orders in the Middle East and Pacific continue to drive the stock higher, Cramer said. SLB was 1% lower to $93.48. Investors are still worried about Allergan (AGN) and its patents, but Cramer said he likes the stock and CEO Dave Pyott is "money in the bank." AGN was flat at $90.47. To sign up for Jim Cramer's free Booyah! newsletter, with all of his latest articles and videos, please click here. -- Written by Bret Kenwell in Petoskey, Mich. Follow @BretKenwell
Hot High Tech Companies To Watch For 2014: Ucore Uranium Inc (UCU.V)
Ucore Rare Metals Inc., a junior exploration company, engages in the exploration and development of rare earth element (REE) and uranium properties. The company�s flagship property includes the Bokan Mountain/Dotson Ridge REE property comprising 422 claims located on the southern end of the Prince of Wales Island in southern Alaska. It also has various properties in Ray Mountains, Alaska; Elliott Lake, Ontario; Greater Newfoundland; Sandybeach Lake, Nunavut; and Lost Pond, Newfoundland. The company was formerly known as Ucore Uranium Inc. and changed its name to Ucore Rare Metals Inc. in June 2010. Ucore Rare Metals Inc. is headquartered in Hammonds Plains, Canada.
Hot High Tech Companies To Watch For 2014: Orion Metals Limited(ORM.AX)
Orion Metals Limited engages in the exploration and evaluation of mineral resource properties in Australia. It primarily explores for gold; uranium; heavy rare earth elements comprising dysprosium, ytterbium, and erbium; and other rare earth and tech metals in Western Australia and Queensland. The company was formerly known as Queensland Gold and Minerals Limited and changed its name to Orion Metals Limited in 2009. Orion Metals Limited was founded in 2001 and is based in East Brisbane, Australia.
Top Casino Companies For 2014: LyondellBasell Industries NV(LYB)
LyondellBasell Industries N.V. manufacturers and sells chemicals and polymers, refines crude oil, produces gasoline blending components, and develops and licenses technologies for production of polymers. The company?s Olefins and Polyolefins segment offers olefins, including ethylene, propylene, and butadiene; aromatics, such as benzene and toluene; polyolefins, which comprise polypropylene (PP), high-density polyethylene, low-density polyethylene, and linear low-density polyethylene; specialty polyolefins, including catalloy process resins, PP compounds, and polybutene-1 resins; and ethylene derivatives, which comprise ethanol. Its Intermediates and Derivatives segment provides propylene oxide (PO); PO co-products, including styrene monomers and TBA derivative isobutylene; PO derivatives, such as propylene glycol, propylene glycol ethers, and butanediol; acetyls, such as methanol, acetic acid, and vinyl acetate monomers; ethylene derivatives, which comprise ethylene oxide , ethylene glycol, and ethylene glycol ethers; and flavor and fragrance chemicals. The company?s Refining and Oxyfuels segment offers gasoline and components, ultra low sulfur diesel, jet fuel, and lube oils; diesel, feedstock, fuel oil, gasoline, and bitumen; and gasoline blending components, including methyl tertiary butyl ether, ethyl tertiary butyl ether, and alkylate. Its Technology segment develops and licenses polyolefin and other process technologies. This segment also develops, manufactures, and sells polyolefin catalysts, as well as provides technology services, which comprise safety reviews, training and start-up assistance, engineering services for process and product improvements, and manufacturing troubleshooting. LyondellBasell Industries N.V. has operations in the Americas, Europe, Asia, and internationally. The company was founded in 2005 and is based in Rotterdam, Netherlands. LyondellBasell Industries N.V. is a subsidiary of Prochemie GmbH.
Advisors' Opinion:- [By Chad Tracy]
In a classic contrarian move, he purchased more shares of troubled plastics-maker LyondellBasell Industries (NYSE: LYB), even as the company was sliding toward bankruptcy.
- [By Chad Tracy]
TransCanada is not the only company that stands to profit from the possible Keystone XL approval. Refiners such as Valero and LyondellBasell Industries (NYSE: LYB), as well as construction companies Deere & Co. (NYSE: DE) and Quanta Services (NYSE: PWR) all stand to gain if Keystone XL gets the green light.
- [By Taylor Muckerman]
Along with Dow, DuPont (NYSE: DD ) and LyondellBasell (NYSE: LYB ) are two companies that have used this access to their advantage. All three will be reporting earnings this week. Motley Fool analyst Taylor Muckerman expects margins to remain relatively high, but the growth we have seen over the past few years might begin to slow. In addition, he touches on some of the future market dynamics that will likely roll out as the available infrastructure continues to increase. Details can be found in the video below.
- [By Tyler Crowe]
This cheap feedstock has sent production up over one-third in the past five years, and has given a nice pad to chemical company earnings. LyondellBassell (NYSE: LYB ) reported that 2012 was a record year in terms of earnings despite a 6% drop in revenue. These kinds of results have resulted in a mad rush to increase�capacity. The entire industry has plans to spend about $30 billion in new plants to take advantage of cheap feedstock. Dow personally is looking to invest $1.7 billion to build what would be the company's largest ethylene facility and would increase the company's ethylene capacity by 1.5 million tons per year. With so much invested in cheap natural gas, it should come as no surprise that the company will look to protect that position for as long as possible.�
Hot High Tech Companies To Watch For 2014: Vitec Group(VTC.L)
The Vitec Group plc, together with its subsidiaries, provides products and services for the broadcast, photographic, military, aerospace, and government markets worldwide. It operates in three divisions: Imaging and Staging, Videocom, and Services. The Imaging and Staging division engages in the design, manufacture, and distribution of equipment and accessories for professionals and amateurs in photography, video, and events fields. This division offers photo, video, and lighting support products; and stage and lighting systems, as well as distributes products for the photographic, video, cine, and lighting production markets. The Videocom division designs and distributes equipment principally for professionals engaged in producing and transporting video content for the media industries, such as broadcast, film, live events, and education, as well as for the military, aerospace, and government markets. It offers bags, camera accessories, lighting products, microwave system s, mobile power systems, prompters, and camera support equipment, as well as equipment rental services. The Services division provides equipment rental, workflow design, and technical support services for camera, video, audio, fiber optic, and wireless technology used by television production teams and film crews. It offers production equipment rental, used production equipment sales, maintenance services, event systems and services, and audio services and sales, as well as fiber optic system design, installation, and maintenance services. The company was formerly known as Vitec Group plc and changed its name to The Vitec Group plc in 2001. The Vitec Group plc was founded in 1910 and is headquartered in Kingston upon Thames, the United Kingdom.
Hot High Tech Companies To Watch For 2014: Myriad Genetics Inc (MYGN.O)
Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The Company is focused on developing and marketing predictive medicine, personalized medicine and prognostic medicine tests. It performs all of its molecular diagnostic testing and analysis in its own reference laboratories. These technologies include the cornerstone technologies of biomarker discovery, high-throughput deoxyribo nucleuc acid (DNA) sequencing, ribo nucleic acid (RNA) expression and multiplex protein analysis. The Company uses this information to guide the development of new molecular diagnostic tests that are designed to assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to drug therapy and guide a patient's dosing to ensure optimal treatment (personalized medicine), or assess a patient's risk of disease progression and disease recurrence (prognostic medicine).
As of June 30, 2012, the Company h ad launched nine commercial molecular diagnostic tests. The Company markets these tests through its own approximate 385-person sales force in the United States. The Company also markets its BRACAnalysis, COLARIS, and COLARIS AP tests through its own European sales force and have entered into marketing collaborations with other organizations in selected Latin American, European and Asian countries. The Company also generates revenue by providing companion diagnostic services to the pharmaceutical, and biotechnology industries and medical research institutions utilizing its multiplexed immunoassay technology.
Molecular Diagnostic Tests
The Company's molecular diagnostic tests are designed to analyze genes, their mutations, expression levels and proteins to assess an individual's risk for developing disease later in life, determine a patient's likelihood of responding to a particular drug, assess a patient's risk of disease progression and disease recu rrence and measure a patient's exposure to drug therapy to! e! nsure optimal dosing and reduced drug toxicity. The Company's BRACAnalysis test is a analysis of the BRCA1 and BRCA2 genes for assessing a woman's risk of developing hereditary breast and ovarian cancer. BRACAnalysis accounted for 81.7% of the Company's total revenue during the fiscal year ended June 30, 2012. Its The Company's COLARIS test is an analysis of the MLH1, MSH2, MSH6 and PMS2 genes for assessing a person's risk of developing colorectal cancer or uterine cancer.
The Company's COLARIS AP test detects mutations in the APC and MYH genes, which cause a colon polyp-forming syndrome known as Familial Adenomatous Polyposis (FAP), a more common variation of the syndrome known as attenuated FAP, and the MYH-associated polyposis signature (MAP). The Company's MELARIS test analyzes mutations in the p16 gene to determine genetic susceptibility to malignant melanoma. The Company's OnDose test is a nanoparticle immunoassay that is designed to assist oncologists in optimizing 5-FU (fluorouracil) anti-cancer drug therapy in colon cancer patients on an individualized basis. The Company's PANEXIA test is a comprehensive analysis of the PALB2 and BRCA2 genes for assessing a person's risk of developing pancreatic cancer later in life. The Company's PREZEON test is an immunohistochemistry test that analyzes the PTEN gene and assesses loss of PTEN function in many cancer types.
The Company's Prolaris test is a 46-gene molecular diagnostic assay that assesses whether a patient is likely to have a slow growing, indolent form of prostate cancer that can be safely monitored through active surveillance, or a more aggressive form of the disease that would warrant aggressive intervention, such as a radical prostatectomy or radiation therapy. The Company's TheraGuide 5-FU test analyzes mutations in the DPYD gene and variations in the TYMS gene to assess patient risk of toxicity to 5-FU (fluorouracil) anti-cancer drug therapy.
< p>Companion Diagnostic Services and Other RevenueThe Company has compiled a library of over 550 individual human and rodent immunoassays for use in its multi-analyte profile (MAP) testing services. The Company has also developed RodentMAP, a panel for use in pre-clinical animal studies and OncologyMAP, which measures cancer-related proteins to assists researchers accelerate the pace of discovery, validation and translation of cancer biomarkers for early detection, patient stratification and therapeu tic monitoring. The Company has developed multiplexed immunoassay kits that enable its customers to leverage its technology services with their in-house capabilities. The Company's internally developed multiplexed immunoassay kits include all of the components necessary for a customer to perform a test on their own Luminex instrument. TruCulture is a simple, self-contained whole blood culture that can be deployed to clinical sites around the world for acquiring cell culture data without specialized facilities or training.
Hot High Tech Companies To Watch For 2014: CarMax Inc(KMX)
CarMax, Inc., through its subsidiaries, operates as a retailer of used vehicles in the United States. It also sells vehicles that do not meet its retail standards to licensed dealers through on-site wholesale auctions, as well as sells new vehicles under franchise agreements. In addition, the company provides customers financing alternatives through its finance operation, CarMax Auto Finance, as well as through its third-party financing providers. Further, it offers a range of other related products and services, including the sale of extended service plans, guaranteed asset protection, and accessories; the appraisal and purchase of vehicles directly from consumers; and vehicle repair services. As of December 21, 2011, the company operated 107 used car superstores in 52 markets. CarMax, Inc. was founded in 1993 and is headquartered in Richmond, Virginia.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on CarMax (NYSE: KMX ) , whose recent revenue and earnings are plotted below. - [By Jon C. Ogg]
CarMax Inc. (NYSE: KMX) was downgraded to Neutral from Buy at Goldman Sachs.
Carnival Corp. (NYSE: CCL) was downgraded to Underweight from Equal Weight at Morgan Stanley. The cruise line operator also was�downgraded to Neutral from Buy at Bank of America Merrill Lynch.
Hot High Tech Companies To Watch For 2014: M.D.C. Holdings Inc. (MDC)
M.D.C. Holdings, Inc., through its subsidiaries, engages in homebuilding and financial services businesses in the United States. Its homebuilding business activities include the purchase of finished lots or development of lots for the construction and sale of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name. The company�s financial services business activities comprise the origination of mortgage loans primarily for homebuyers; provision of third-party insurance products to homebuyers; and title agency services to homebuyers in Colorado, Florida, Maryland, Nevada, and Virginia. It also provides insurance coverage on homes sold and for work performed in completed subdivisions; and re-insures the claims. M.D.C. Holdings, Inc. was founded in 1972 and is based in Denver, Colorado.
Advisors' Opinion:- [By John Buckingham, Chief Investment Officer, Al Frank Asset Management, Inc. (AFAM)]
MDC Holdings (MDC) is a builder and seller of homes in California, Colorado, Maryland, Virginia, Arizona, and Nevada under the name Richmond American Homes, and an originator of mortgage loans for home buyers.
Hot High Tech Companies To Watch For 2014: Scancell Holdings PLC (SCLP.L)
Scancell Holdings PLC is a United Kingdom-based company. The Company�� principal activity of the consists of the discovery and development of monoclonal antibodies and vaccines for the treatment of cancer. In April 2012, the Company completed recruitment to the Phase 1 clinical trial of SCIBI. In May 2012, the Company commenced recruitment and treatment of the first patient in the second part of it Phase 1/2 clinical trial of SCIBI. The Phase 2 part of the trial is conducted in five United Kingdom centers in Nottingham, Manchester, Newcastle, Leeds, and Southampton. On August 15, 2012, the Company announced the development of a platform technology, Moditope.
No comments:
Post a Comment